1. Rocha-Filho, P.A., Gherpelli, J.L., de Siqueira, J.T.Rabello, G.D. Post-craniotomy headache: characteristics, behaviour and effect on quality of life in patients operated for treatment of supratentorial intracranial aneurysms. Cephalalgia 2008;28(1):41-8.
2. Bassi, P., Bandera, R., Loiero, M., Tognoni, G.Mangoni, A. Warning signs in subarachnoid hemorrhage: a cooperative study. Acta Neurol Scand 1991;84(4):277-81.
3. Morad, A.H., Tamargo, R.J.Gottschalk, A. The Longitudinal Course of Pain and Analgesic Therapy Following Aneurysmal Subarachnoid Hemorrhage: A Cohort Study. Headache 2016;56(10):1617-25.
4. Viswanathan, V., Lucke-Wold, B., Jones, C., et al. Change in opioid and analgesic use for headaches after aneurysmal subarachnoid hemorrhage over time. Neurochirurgie 2021.
5. Jaffa, M.N., Podell, J.E., Smith, M.C., et al. Association of Refractory Pain in the Acute Phase After Subarachnoid Hemorrhage with Continued Outpatient Opioid Use. Neurology 2021.
6. Huckhagel, T., Klinger, R., Schmidt, N.O., et al. The burden of headache following aneurysmal subarachnoid hemorrhage: a prospective single-center cross-sectional analysis. Acta Neurochir (Wien) 2020;162(4):893-903.
7. de Biase, S., Longoni, M., Gigli, G.L.Agostoni, E. Headache and endovascular procedures. Neurol Sci 2017;38(Suppl 1):77-80.
8. Diringer, M.N., Bleck, T.P., Claude Hemphill, J., 3rd, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care 2011;15(2):211-40.
9. Steiner, T., Juvela, S., Unterberg, A., et al. European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc Dis 2013;35(2):93-112.
10. Kvolik, S., Koruga, N.Skiljic, S. Analgesia in the Neurosurgical Intensive Care Unit. Front Neurol 2021;12:819613.
11. Martyn, J.A.J., Mao, J.Bittner, E.A. Opioid Tolerance in Critical Illness. N Engl J Med 2019;380(4):365-78.
12. Viswanathan, V., Lucke-Wold, B., Jones, C., et al. Change in opioid and analgesic use for headaches after aneurysmal subarachnoid hemorrhage over time. Neurochirurgie 2021;67(5):427-32.
13. Dhakal, L.P., Turnbull, M.T., Jackson, D.A., et al. Safety, Tolerability, and Efficacy of Pain Reduction by Gabapentin for Acute Headache and Meningismus After Aneurysmal Subarachnoid Hemorrhage: A Pilot Study. Front Neurol 2020;11:744.
14. Hile, G.B.Cook, A.M. Treatment of headache in aneurysmal subarachnoid hemorrhage: Multimodal approach. Interdisciplinary Neurosurgery 2020;22:100857.
15. Smith, C.R., Dickinson, K.J., Carrazana, G., et al. Ultrasound-Guided Suprazygomatic Nerve Blocks to the Pterygopalatine Fossa: A Safe Procedure. Pain Med 2022.
16. Smith, C.R., Fox, W.C., Robinson, C.P., et al. Pterygopalatine Fossa Blockade as Novel, Narcotic-Sparing Treatment for Headache in Patients with Spontaneous Subarachnoid Hemorrhage. Neurocrit Care 2021.
17. Jaffa, M.N., Jha, R.M., Elmer, J., et al. Pain Trajectories Following Subarachnoid Hemorrhage are Associated with Continued Opioid Use at Outpatient Follow-up. Neurocrit Care 2021.
18. Eisinger, R.S., Sorrentino, Z.A., Lucke-Wold, B., et al. Severe headache trajectory following aneurysmal subarachnoid hemorrhage: the association with lower sodium levels. Brain Inj 2022:1-7.
19. Shan, G., Exact Statistical Inference for Categorical Data, ed. G. Shan2016: Academic Press. 1-27.
20. Team, R. RStudio: Integrated Development for R. 2020.
21. Glisic, E.K., Gardiner, L., Josti, L., et al. Inadequacy of Headache Management After Subarachnoid Hemorrhage. Am J Crit Care 2016;25(2):136-43.
22. Klavansky, D., Wanchoo, S., Lin, A., Temes, R.E.Rebeiz, T. Predictors of Opiate Utilization in the Treatment of Headache and Impact on Three-Month Outcomes Following Subarachnoid Hemorrhage. Cureus 2021;13(12):e20773.
23. Cooley, R., Venkatachalam, A.M., Aguilera, V., Olson, D.M.Stutzman, S.E. A Qualitative Study of Nurses' Perceptions of Narcotic Administration after Subarachnoid Hemorrhage. Pain Manag Nurs 2021.
24. Friedman, B.W., Irizarry, E., Solorzano, C., et al. Randomized study of IV prochlorperazine plus diphenhydramine vs IV hydromorphone for migraine. Neurology 2017;89(20):2075-82.
25. Giamberardino, M.A., Affaitati, G., Costantini, R., Guglielmetti, M.Martelletti, P. Acute headache management in emergency department. A narrative review. Intern Emerg Med 2020;15(1):109-17.
26. Swart, L.M., van der Zanden, V., Spies, P.E., de Rooij, S.E.van Munster, B.C. The Comparative Risk of Delirium with Different Opioids: A Systematic Review. Drugs Aging 2017;34(6):437-43.
27. Barr, J., Fraser, G.L., Puntillo, K., et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 2013;41(1):263-306.
28. Wilson, N., Kariisa, M., Seth, P., Smith, H.t.Davis, N.L. Drug and Opioid-Involved Overdose Deaths - United States, 2017-2018. MMWR Morb Mortal Wkly Rep 2020;69(11):290-7.
29. Gomes, T., Khuu, W., Martins, D., et al. Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada. Bmj 2018;362:k3207.
30. Higgins, C., Smith, B.H.Matthews, K. Incidence of iatrogenic opioid dependence or abuse in patients with pain who were exposed to opioid analgesic therapy: a systematic review and meta-analysis. Br J Anaesth 2018;120(6):1335-44.
31. Bigal, M.E., Serrano, D., Buse, D., et al. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 2008;48(8):1157-68.
32. Diener, H.C., Holle, D., Solbach, K.Gaul, C. Medication-overuse headache: risk factors, pathophysiology and management. Nat Rev Neurol 2016;12(10):575-83.
33. van den Brink, W., Pierce, M.van Amsterdam, J. What lessons from Europe's experience could be applied in the United States in response to the opioid addiction and overdose crisis? Addiction 2022;117(5):1197-8.
34. Fischer, B., Keates, A., Buhringer, G., Reimer, J.Rehm, J. Non-medical use of prescription opioids and prescription opioid-related harms: why so markedly higher in North America compared to the rest of the world? Addiction 2014;109(2):177-81.
35. van Amsterdam, J., Pierce, M.van den Brink, W. Is Europe Facing an Emerging Opioid Crisis Comparable to the U.S.? Ther Drug Monit 2021;43(1):42-51.
36. Dorhout Mees, S.M., Bertens, D., van der Worp, H.B., Rinkel, G.J.van den Bergh, W.M. Magnesium and headache after aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 2010;81(5):490-3.
37. Lionel, K.R., Sethuraman, M., Abraham, M., et al. Effect of Pregabalin on Perioperative Headache in Patients with Aneurysmal Subarachnoid Hemorrhage: A Randomized Double-Blind, Placebo-Controlled Trial. J Neurosci Rural Pract 2019;10(3):438-43.
38. Czorlich, P., Sauvigny, T., Ricklefs, F., et al. Impact of dexamethasone in patients with aneurysmal subarachnoid haemorrhage. Eur J Neurol 2017;24(4):645-51.
39. Miller, M.M., Dakay, K., Henninger, N., et al. Association of Dexamethasone with Shunt Requirement, Early Disability, and Medical Complications in Aneurysmal Subarachnoid Hemorrhage. Neurocrit Care 2021;34(3):760-8.
40. Dietzel, J., Eck, T.Usichenko, T. Treating Therapy-Resistant Headache After Aneurysmal Subarachnoid Hemorrhage with Acupuncture. Neurocrit Care 2019;31(2):434-8.
41. Doğan, R., Pınar, H.U., Karaca, Ö.Karakoç, F. Ultrasound-guided bilateral greater occipital nerve block on headache seen after endovascular treatment of ruptured or unruptured intracranial aneurysms: A case report. Agri 2020;32(4):223-7.
42. Rumalla, K., Smith, K.A., Arnold, P.M.Mittal, M.K. Subarachnoid Hemorrhage and Readmissions: National Rates, Causes, Risk Factors, and Outcomes in 16,001 Hospitalized Patients. World Neurosurg 2018;110:e100-e11.
43. Haug Nordenmark, T., Karic, T., Røe, C., Sorteberg, W.Sorteberg, A. The post-aSAH syndrome: a self-reported cluster of symptoms in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 2019;132(5):1556-65.